The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal cell carcinoma (mRCC). A total of 706patients with mRCC treated with tyrosine kinase inhibitors (TKIs)between January 2007 and June 2020 (i....

Descripción completa

Detalles Bibliográficos
Autores principales: Yücel, Kadriye Bir, Yekedüz, Emre, Karakaya, Serdar, Tural, Deniz, Ertürk, İsmail, Erol, Cihan, Ercelep, Özlem, Öztaş, Nihan Şentürk, Arslan, Çağatay, Uçar, Gökhan, Küçükarda, Ahmet, Sever, Özlem Nuray, Kılıçkap, Saadettin, Can, Orçun, Yazgan, Satı Coşkun, Öksüzoğlu, Berna, Karadurmuş, Nuri, Şendur, Mehmet Ali, Ürün, Yüksel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529965/
https://www.ncbi.nlm.nih.gov/pubmed/36192500
http://dx.doi.org/10.1038/s41598-022-20056-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529965/
https://www.ncbi.nlm.nih.gov/pubmed/36192500
http://dx.doi.org/10.1038/s41598-022-20056-3

Ejemplares similares